In the News

New research on mixed vaccine boosters, long-term outcomes, omicron severity

A study found mixing and matching of COVID-19 vaccines to be safe and effective, other research showed ongoing symptoms to be common at one year after infection, the CDC analyzed the severity of omicron, and the FDA revised outpatient treatment authorizations.

Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VIII: Outpatient Evaluation and Management of Patients with COVID-19

During the Feb. 9 virtual live event, a panel of experts will discuss appropriate COVID-19 testing, quarantine and isolation periods, management of symptoms, and recommended treatments in the outpatient setting.

Task Force finds insufficient evidence on screening for afib

The U.S. Preventive Services Task Force reviewed trials published since 2017 but did not deem them strong enough to show evidence of benefit or harm.

MKSAP Quiz: Abdominal pain for several months

A 56-year-old man is evaluated for right-upper-quadrant abdominal pain of several months' duration. He otherwise has been well. Following a physical exam, lab studies, and other tests, what is the most appropriate diagnostic test to perform next?

Long-acting injectable cabotegravir not cost-effective for HIV PrEP

While the long-acting injectable form of cabotegravir has shown superior effectiveness for HIV pre-exposure prophylaxis (PrEP), a cost-effectiveness analysis found that the drug is too expensive at its current price compared to the daily oral medication available as a generic.

ACP's Pain Management Learning Hub releases new learning materials

Each of the new peer-to-peer activities provides opportunities for ACP members to earn free CME/MOC credit and meet many state-based CME requirements.

Put words in our mouth

ACP Internist Weekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.